Literature DB >> 12052977

Chlamydia pneumoniae seropositivity is associated with increased plasma levels of soluble cellular adhesion molecules in community-dwelling subjects: the Shimanami Health Promoting Program (J-SHIPP) study.

Katsuhiko Kohara1, Yasuharu Tabara, Yoshikuni Yamamoto, Michiya Igase, Tetsuro Miki.   

Abstract

BACKGROUND AND
PURPOSE: In vitro studies have demonstrated that Chlamydia pneumoniae infection of the endothelium increases the expression of adhesion molecules and chemokines, indicating that C pneumoniae infection affects the adhesion and recruitment of leukocytes to the endothelium, which is believed to be involved in the initial steps of atherosclerosis. However, whether chronic C pneumoniae infection increases these molecules in vivo has not been elucidated.
METHODS: The association between C pneumoniae seropositivity and plasma concentrations of soluble adhesion molecules and a chemokine was investigated in 200 community-dwelling residents free from cardiovascular diseases and medication. Plasma levels of IgA and IgG antibodies to C pneumoniae were measured by enzyme-linked immunosorbent assay. Indices of IgG and IgA antibodies were determined as the ratio to the standardized positive control. The subjects were divided into 3 groups according to the indices of antibodies: C pneumoniae seronegative (n=57, IgA<1.0 and IgG<1.0), C pneumoniae intermediate (n=81, 1.0< or =IgA> or =1.1 or 1.0< or =IgG> or =1.1), and C pneumoniae seropositive (n=62, IgA>1.1 and IgG>1.1). Plasma concentrations of soluble forms of intercellular adhesion molecule-1 (ICAM-1), vascular cellular adhesion molecule-1, and monocyte chemoattractant protein-1 were determined by enzyme-linked immunosorbent assay.
RESULTS: Plasma concentrations of ICAM-1 (392+/-118, 398+/-94, 470+/-154 ng/mL, P=0.0004) and vascular cellular adhesion molecule-1 (402+/-146, 419+/-130, 472+/-181 ng/mL, P=0.03) were significantly different among the C pneumoniae seronegative, intermediate, and seropositive groups respectively. However, plasma monocyte chemoattractant protein-1 was not significantly different among the 3 groups. Stepwise regression analysis showed that plasma concentration of ICAM-1 was significantly associated with C pneumoniae seropositivity, independent of other known risk factors for atherosclerosis and carotid intima-media thickness.
CONCLUSION: These findings indicate that C pneumoniae seropositivity is associated with higher plasma concentrations of soluble forms of adhesion molecules in the general population. The increase in circulating adhesion molecules may underlie the mechanisms linking C pneumoniae infection and atherosclerosis in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12052977     DOI: 10.1161/01.str.0000018974.05768.fb

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  3 in total

1.  Relationship Among Chlamydia and Mycoplasma Pneumoniae Seropositivity, IKZF1 Genotype and Chronic Obstructive Pulmonary Disease in A General Japanese Population: The Nagahama Study.

Authors:  Shigeo Muro; Yasuharu Tabara; Hisako Matsumoto; Kazuya Setoh; Takahisa Kawaguchi; Meiko Takahashi; Isao Ito; Yutaka Ito; Kimihiko Murase; Chikashi Terao; Shinji Kosugi; Ryo Yamada; Akihiro Sekine; Takeo Nakayama; Kazuo Chin; Michiaki Mishima; Fumihiko Matsuda
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

2.  GroEL1, from Chlamydia pneumoniae, induces vascular adhesion molecule 1 expression by p37(AUF1) in endothelial cells and hypercholesterolemic rabbit.

Authors:  Chun-Yao Huang; Chun-Ming Shih; Nai-Wen Tsao; Yung-Hsiang Chen; Chi-Yuan Li; Yu-Jia Chang; Nen-Chung Chang; Keng-Liang Ou; Cheng-Yen Lin; Yi-Wen Lin; Chih-Hao Nien; Feng-Yen Lin
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

3.  GroEL1, a heat shock protein 60 of Chlamydia pneumoniae, impairs neovascularization by decreasing endothelial progenitor cell function.

Authors:  Yi-Wen Lin; Chun-Yao Huang; Yung-Hsiang Chen; Chun-Ming Shih; Nai-Wen Tsao; Cheng-Yen Lin; Nen-Chung Chang; Chien-Sung Tsai; Hsiao-Ya Tsai; Jui-Chi Tsai; Po-Hsun Huang; Chi-Yuan Li; Feng-Yen Lin
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.